BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35660381)

  • 1. Low-dose hexavalent chromium(VI) exposure promotes prostate cancer cell proliferation by activating MAGEB2-AR signal pathway.
    Qie Y; Zhou D; Wu Z; Liu S; Shen C; Hu H; Zhang C; Xu Y
    Ecotoxicol Environ Saf; 2022 Aug; 241():113724. PubMed ID: 35660381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromium(VI) promotes cell migration through targeting epithelial-mesenchymal transition in prostate cancer.
    Zhang C; Cai K; Feng Q; Xu Y; Zhang Z
    Toxicol Lett; 2019 Jan; 300():10-17. PubMed ID: 30315950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-mesenchymal transition during oncogenic transformation induced by hexavalent chromium involves reactive oxygen species-dependent mechanism in lung epithelial cells.
    Ding SZ; Yang YX; Li XL; Michelli-Rivera A; Han SY; Wang L; Pratheeshkumar P; Wang X; Lu J; Yin YQ; Budhraja A; Hitron AJ
    Toxicol Appl Pharmacol; 2013 May; 269(1):61-71. PubMed ID: 23518002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Hexavalent Chromium Exposure Induces Cancer Stem Cell-Like Property and Tumorigenesis by Increasing c-Myc Expression.
    Wang Z; Lin HP; Li Y; Tao H; Yang P; Xie J; Maddy D; Kondo K; Yang C
    Toxicol Sci; 2019 Dec; 172(2):252-264. PubMed ID: 31504995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hexavalent Chromium (Cr(VI)) Down-Regulates Acetylation of Histone H4 at Lysine 16 through Induction of Stressor Protein Nupr1.
    Chen D; Kluz T; Fang L; Zhang X; Sun H; Jin C; Costa M
    PLoS One; 2016; 11(6):e0157317. PubMed ID: 27285315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAGE4 positivity is associated with attenuated AR signaling and predicts patient survival in hormone-naive prostate cancer.
    Sampson N; Ruiz C; Zenzmaier C; Bubendorf L; Berger P
    Am J Pathol; 2012 Oct; 181(4):1443-54. PubMed ID: 22885105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of histone-lysine methyltransferases plays a causal role in hexavalent chromium-induced cancer stem cell-like property and cell transformation.
    Wang Z; Wu J; Humphries B; Kondo K; Jiang Y; Shi X; Yang C
    Toxicol Appl Pharmacol; 2018 Mar; 342():22-30. PubMed ID: 29391238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene 33/Mig6 inhibits hexavalent chromium-induced DNA damage and cell transformation in human lung epithelial cells.
    Park S; Li C; Zhao H; Darzynkiewicz Z; Xu D
    Oncotarget; 2016 Feb; 7(8):8916-30. PubMed ID: 26760771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling.
    Hu S; Li L; Yeh S; Cui Y; Li X; Chang HC; Jin J; Chang C
    Mol Oncol; 2015 Jan; 9(1):44-57. PubMed ID: 25135278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of hedgehog-interacting protein (HHIP) contributes to hexavalent chromium-induced malignant transformation of human bronchial epithelial cells.
    Li P; Zhang X; Murphy AJ; Costa M; Zhao X; Sun H
    Carcinogenesis; 2021 Feb; 42(1):136-147. PubMed ID: 32710611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of particulate hexavalent chromium cytotoxicity and genotoxicity in human and leatherback sea turtle lung cells from a one environmental health perspective.
    Speer RM; Wise SS; Croom-Perez TJ; Aboueissa AM; Martin-Bras M; Barandiaran M; Bermúdez E; Wise JP
    Toxicol Appl Pharmacol; 2019 Aug; 376():70-81. PubMed ID: 31108106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers.
    Minges JT; Su S; Grossman G; Blackwelder AJ; Pop EA; Mohler JL; Wilson EM
    J Biol Chem; 2013 Jan; 288(3):1939-52. PubMed ID: 23172223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique targeting of androgen-dependent and -independent AR signaling in prostate cancer to overcome androgen resistance.
    Lim SC; Jansson PJ; Assinder SJ; Maleki S; Richardson DR; Kovacevic Z
    FASEB J; 2020 Sep; 34(9):11511-11528. PubMed ID: 32713076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP.
    Karpf AR; Bai S; James SR; Mohler JL; Wilson EM
    Mol Cancer Res; 2009 Apr; 7(4):523-35. PubMed ID: 19372581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation modifications induced by hexavalent chromium.
    Guo X; Feng L; Lemos B; Lou J
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2019; 37(3):133-145. PubMed ID: 31084241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Throughput Screening Data Interpretation in the Context of In Vivo Transcriptomic Responses to Oral Cr(VI) Exposure.
    Rager JE; Ring CL; Fry RC; Suh M; Proctor DM; Haws LC; Harris MA; Thompson CM
    Toxicol Sci; 2017 Jul; 158(1):199-212. PubMed ID: 28472532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms.
    O'Brien TJ; Ceryak S; Patierno SR
    Mutat Res; 2003 Dec; 533(1-2):3-36. PubMed ID: 14643411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of miR-143 mediates Cr (VI)-induced tumor angiogenesis via IGF-IR/IRS1/ERK/IL-8 pathway.
    He J; Qian X; Carpenter R; Xu Q; Wang L; Qi Y; Wang ZX; Liu LZ; Jiang BH
    Toxicol Sci; 2013 Jul; 134(1):26-38. PubMed ID: 23748240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Cr(VI)-Induced Premature Senescence in L02 Hepatocytes by ROS-Ca
    Zhang Y; Yang G; Huang S; Yang X; Yuan F; Song Y; Liu S; Yu X
    Oxid Med Cell Longev; 2022; 2022():7295224. PubMed ID: 35222804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer.
    Ding M; Jiang CY; Zhang Y; Zhao J; Han BM; Xia SJ
    J Exp Clin Cancer Res; 2020 Feb; 39(1):28. PubMed ID: 32019578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.